WHO

The R21/Matrix-M malaria vaccine has been recommended for use by the World Health Organization’s Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG). Developed by The University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, R21/Matrix-M malaria vaccine demonstrates high efficacy with a reassuring safety profile. It […]

Research into antibiotic-resistant priority pathogens has boomed in the five years since the World Health Organisation (WHO) released a list of 12 families of bacteria that desperately need new antibiotics.  Data from Elseveir’s Scopus database show that since 2017, 227,808 papers have been published on the 12 pathogens. The WHO released a list of bacteria […]

The World Health Organisation (WHO) has released an update to its ongoing global Covid-19 strategy in order to reach individuals yet to be vaccinated.   The update to WHO’s Global Covid-19 Vaccination Strategy1, was made in response to the spread of Omicron subvariants, advances in vaccine evidence, and lessons from the global vaccination programme, the organisation […]

Urgent access to vaccines that can fight and prevent infections, and curb the risk of antimicrobial resistance (AMR) is needed to save lives, according to a report by the World Health Organisation (WHO).  WHO has released the first-ever report1 looking at the pipeline of vaccines currently in development to fight infections caused by (AMR)  It […]

The World Health Organisation (WHO) has strongly recommended a combination of antiviral drugs for patients at a high risk of hospital admission due to Covid-19.   The WHO is recommending Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) for patients with non-severe covid-19 who are at highest risk of hospitalisation, such as unvaccinated, […]